{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:49:40Z","timestamp":1793638180785,"version":"4.5.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ucl.2017.04.009","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T04:48:05Z","timestamp":1500094085000},"page":"429-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Chronic Urinary Retention in Multiple Sclerosis Patients"],"prefix":"10.1016","volume":"44","author":[{"given":"John T.","family":"Stoffel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ucl.2017.04.009_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.disamonth.2013.03.012","article-title":"Management of multiple sclerosis: an overview","volume":"59","author":"Rubin","year":"2013","journal-title":"Dis Mon"},{"issue":"4","key":"10.1016\/j.ucl.2017.04.009_bib2","first-page":"1432","article-title":"Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS patient registry","volume":"183","author":"Mahajan","year":"2010","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2017.04.009_bib3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s11136-013-0535-1","article-title":"Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study","volume":"23","author":"Tepavcevic","year":"2014","journal-title":"Qual Life Res"},{"issue":"2","key":"10.1016\/j.ucl.2017.04.009_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ucl.2017.04.009_bib5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/jnnp-2014-308675","article-title":"Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria","volume":"86","author":"Brownlee","year":"2015","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.ucl.2017.04.009_bib6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7224\/1537-2073.2016-051","article-title":"CME\/CNE article: a framework of care in multiple sclerosis, part 1: updated disease classification and disease-modifying therapy use in specific circumstances","volume":"18","author":"Newsome","year":"2016","journal-title":"Int J MS Care"},{"issue":"5","key":"10.1016\/j.ucl.2017.04.009_bib7","first-page":"470","article-title":"A\u00a0UK consensus on the management of the bladder in multiple sclerosis","volume":"80","author":"Fowler","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"14","key":"10.1016\/j.ucl.2017.04.009_bib8","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1177\/1352458513489758","article-title":"First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm","volume":"19","author":"Amarenco","year":"2013","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.ucl.2017.04.009_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10072-015-2415-7","article-title":"Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances","volume":"37","author":"Ghezzi","year":"2016","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.ucl.2017.04.009_bib10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.eururo.2012.02.036","article-title":"Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis","volume":"62","author":"Madhuvrata","year":"2012","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.ucl.2017.04.009_bib11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s12325-013-0054-z","article-title":"OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology","volume":"30","author":"Ginsberg","year":"2013","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.ucl.2017.04.009_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2005.00431.x","article-title":"Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis","volume":"112","author":"Bosma","year":"2005","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"10.1016\/j.ucl.2017.04.009_bib13","first-page":"2201","article-title":"Urinary diversion\/reconstruction for cases of catheter intolerant secondary progressive multiple sclerosis with refractory urinary symptoms","volume":"185","author":"DeLong","year":"2011","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.ucl.2017.04.009_bib14","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.urology.2012.06.039","article-title":"Prospective evaluation of laparoscopic assisted cystectomy and ileal conduit in advanced multiple sclerosis","volume":"80","author":"Guillotreau","year":"2012","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.ucl.2017.04.009_bib15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1179\/2045772312Y.0000000084","article-title":"The prevalence of urinary catheterization in women and men with multiple sclerosis","volume":"36","author":"Mahajan","year":"2013","journal-title":"J\u00a0Spinal Cord Med"},{"issue":"5","key":"10.1016\/j.ucl.2017.04.009_bib16","first-page":"2072","article-title":"Collagen directly stimulates bladder smooth muscle cell growth in\u00a0vitro: regulation by extracellular regulated mitogen activated protein kinase","volume":"170","author":"Herz","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.ucl.2017.04.009_bib17","first-page":"758","article-title":"Effects of alpha 1-adrenergic receptor subtype selective antagonists on lower urinary tract function in rats with bladder outlet obstruction","volume":"172","author":"Gu","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.ucl.2017.04.009_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ucl.2010.06.006","article-title":"Basic bladder neurophysiology","volume":"37","author":"Clemens","year":"2010","journal-title":"Urol Clin North Am"},{"issue":"8","key":"10.1016\/j.ucl.2017.04.009_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bjp.0706147","article-title":"Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing","volume":"144","author":"Mansfield","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.ucl.2017.04.009_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2012.01.022","article-title":"Role of M2 and M3 muscarinic acetylcholine receptor subtypes in activation of bladder afferent pathways in spinal cord injured rats","volume":"79","author":"Matsumoto","year":"2012","journal-title":"Urology"},{"issue":"10","key":"10.1016\/j.ucl.2017.04.009_bib21","doi-asserted-by":"crossref","first-page":"e0141493","DOI":"10.1371\/journal.pone.0141493","article-title":"Urinary retention, incontinence, and dysregulation of muscarinic receptors in male mice lacking Mras","volume":"10","author":"Ehrhardt","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ucl.2017.04.009_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1442-2042.2012.03210.x","article-title":"Nervous network for lower urinary tract function","volume":"20","author":"Birder","year":"2013","journal-title":"Int J Urol"},{"issue":"5","key":"10.1016\/j.ucl.2017.04.009_bib23","first-page":"2504","article-title":"Mechanosensitive primary bladder afferent activity in rats with and without spinal cord transection","volume":"182","author":"Iijima","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2017.04.009_bib24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/nau.20765","article-title":"Aging and the underactive detrusor: a failure of activity or activation?","volume":"29","author":"Smith","year":"2010","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.ucl.2017.04.009_bib25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1464-410X.2009.08819.x","article-title":"A\u00a0functional magnetic resonance imaging study of the effect of sacral neuromodulation on brain responses in women with Fowler's syndrome","volume":"105","author":"Kavia","year":"2010","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.ucl.2017.04.009_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrn2401","article-title":"The neural control of micturition","volume":"9","author":"Fowler","year":"2008","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.ucl.2017.04.009_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1152\/jn.1996.76.1.215","article-title":"Unitary excitatory synaptic currents in preganglionic neurons mediated by two distinct groups of interneurons in neonatal rat sacral parasympathetic nucleus","volume":"76","author":"Araki","year":"1996","journal-title":"J\u00a0Neurophysiol"},{"issue":"1","key":"10.1016\/j.ucl.2017.04.009_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jneuroim.2008.06.038","article-title":"Bladder dysfunction in mice with experimental autoimmune encephalomyelitis","volume":"203","author":"Altuntas","year":"2008","journal-title":"J\u00a0Neuroimmunol"},{"issue":"4","key":"10.1016\/j.ucl.2017.04.009_bib29","first-page":"1384","article-title":"Relationship of bladder dysfunction to lesion site in multiple sclerosis","volume":"169","author":"Araki","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.ucl.2017.04.009_bib30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/nau.22953","article-title":"The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis","volume":"36","author":"Weissbart","year":"2017","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"10.1016\/j.ucl.2017.04.009_bib31","first-page":"438","article-title":"Functional magnetic resonance imaging with concurrent urodynamic testing identifies brain structures involved in micturition cycle in patients with multiple sclerosis","volume":"197","author":"Khavari","year":"2017","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2017.04.009_bib32","first-page":"127","article-title":"Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment\u00a0strategies","volume":"5","author":"Stoffel","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.ucl.2017.04.009_bib33","article-title":"AUA white paper: non-neurogenic chronic urinary retention: consensus definition, treatment algorithm, and outcome endpoints","author":"Stoffel","year":"2017","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.ucl.2017.04.009_bib34","first-page":"1549","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association","volume":"148","author":"Barry","year":"1992","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.ucl.2017.04.009_bib35","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/nau.10075","article-title":"Test-retest reliability, validity, and sensitivity to change of the urogenital distress inventory and the incontinence impact questionnaire","volume":"21","author":"Hagen","year":"2002","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"10.1016\/j.ucl.2017.04.009_bib36","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/nau.22468","article-title":"The Michigan Incontinence Symptom Index (M-ISI): a clinical measure for type, severity, and bother related to urinary incontinence","volume":"33","author":"Suskind","year":"2014","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"10.1016\/j.ucl.2017.04.009_bib37","first-page":"452","article-title":"The validity and reliability of the neurogenic bladder symptom score","volume":"192","author":"Welk","year":"2014","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.ucl.2017.04.009_bib38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7224\/1537-2073.2012-049","article-title":"Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients","volume":"15","author":"Burks","year":"2013","journal-title":"Int J MS Care"},{"issue":"3","key":"10.1016\/j.ucl.2017.04.009_bib39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ucl.2014.04.004","article-title":"Urodynamics in the evaluation of the patient with multiple sclerosis: when are they helpful and how do we use them?","volume":"41","author":"Dillon","year":"2014","journal-title":"Urol Clin North Am"},{"issue":"3","key":"10.1016\/j.ucl.2017.04.009_bib40","first-page":"743","article-title":"Multiple sclerosis and the urologist","volume":"161","author":"Litwiller","year":"1999","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2017.04.009_bib41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0003-9993(98)90003-X","article-title":"Vesicourethral dysfunction and urodynamic findings in multiple sclerosis: a study of 149 cases","volume":"79","author":"Gallien","year":"1998","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"10.1016\/j.ucl.2017.04.009_bib42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000117359","article-title":"Efficient treatment of\u00a0neurogenic bladder disorders in multiple sclerosis\u00a0with initial intermittent catheterization and ultrasound-controlled training","volume":"30","author":"Kornhuber","year":"1990","journal-title":"Eur Neurol"},{"issue":"7","key":"10.1016\/j.ucl.2017.04.009_bib43","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/1352458506075651","article-title":"The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines","volume":"13","author":"de Seze","year":"2007","journal-title":"Mult Scler"},{"issue":"9","key":"10.1016\/j.ucl.2017.04.009_bib44","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1177\/1352458512474089","article-title":"Renal deterioration in multiple sclerosis patients with neurovesical dysfunction","volume":"19","author":"Fletcher","year":"2013","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.ucl.2017.04.009_bib45","first-page":"48","article-title":"Tamsulosin in the treatment of detrusor-sphincter dyssynergia of the urinary bladder in patients with multiple sclerosis","author":"Stankovich","year":"2004","journal-title":"Urologiia"},{"issue":"4","key":"10.1016\/j.ucl.2017.04.009_bib46","first-page":"1114","article-title":"Do alpha-blockers have a role in lower urinary tract dysfunction in multiple sclerosis?","volume":"153","author":"O'Riordan","year":"1995","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.ucl.2017.04.009_bib47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.rehab.2014.05.007","article-title":"Self-intermittent catheterization in multiple sclerosis","volume":"57","author":"Wyndaele","year":"2014","journal-title":"Ann Phys Rehabil Med"},{"issue":"3","key":"10.1016\/j.ucl.2017.04.009_bib48","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/1352458508098599","article-title":"Clean intermittent self-catheterization in persons with multiple sclerosis: the influence of cognitive dysfunction","volume":"15","author":"Vahter","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.ucl.2017.04.009_bib49","doi-asserted-by":"crossref","first-page":"167030","DOI":"10.1155\/2014\/167030","article-title":"Urinary catheterization may not adversely impact quality of life in multiple sclerosis patients","volume":"2014","author":"James","year":"2014","journal-title":"ISRN Neurol"},{"key":"10.1016\/j.ucl.2017.04.009_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/sc.2016.192","article-title":"Outcome\u00a0comparison of different approaches to self-intermittent catheterization in neurogenic patients: a systematic review","author":"Shamout","year":"2017","journal-title":"Spinal Cord"},{"issue":"12","key":"10.1016\/j.ucl.2017.04.009_bib51","article-title":"Urethral (indwelling or intermittent) or suprapubic routes for short-term catheterisation in hospitalised adults","author":"Kidd","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ucl.2017.04.009_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/nau.20146","article-title":"Outcome of urethral closure in patients with neurologic impairment and complete urethral destruction","volume":"25","author":"Stoffel","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ucl.2017.04.009_bib53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12894-015-0102-x","article-title":"Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series","volume":"15","author":"Engeler","year":"2015","journal-title":"BMC Urol"},{"issue":"2","key":"10.1016\/j.ucl.2017.04.009_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00192-009-1023-6","article-title":"Sacral neuromodulation for multiple sclerosis patients with urinary retention and clean intermittent catheterization","volume":"21","author":"Marinkovic","year":"2010","journal-title":"Int Urogynecol J"},{"issue":"1","key":"10.1016\/j.ucl.2017.04.009_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00345-011-0669-0","article-title":"Sacral neuromodulation in patients with multiple sclerosis","volume":"30","author":"Minardi","year":"2012","journal-title":"World J Urol"},{"issue":"12","key":"10.1016\/j.ucl.2017.04.009_bib56","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1177\/1352458511414040","article-title":"Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial","volume":"17","author":"Gobbi","year":"2011","journal-title":"Mult Scler"},{"issue":"8","key":"10.1016\/j.ucl.2017.04.009_bib57","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/nau.20733","article-title":"The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction","volume":"28","author":"Kabay","year":"2009","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.ucl.2017.04.009_bib58","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/nau.20958","article-title":"Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study","volume":"30","author":"de Seze","year":"2011","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1016\/j.ucl.2017.04.009_bib59","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00192-015-2814-6","article-title":"Posterior tibial nerve stimulation in the management of lower urinary tract symptoms in patients with multiple sclerosis","volume":"27","author":"Zecca","year":"2016","journal-title":"Int Urogynecol J"},{"issue":"12","key":"10.1016\/j.ucl.2017.04.009_bib60","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/jnnp.2004.045765","article-title":"Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients","volume":"76","author":"Gallien","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.ucl.2017.04.009_bib61","article-title":"Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction","author":"Utomo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ucl.2017.04.009_bib62","first-page":"106","article-title":"Vesicourethral dysfunction associated with multiple sclerosis: clinical and urodynamic perspectives","volume":"160","author":"Barbalias","year":"1998","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.ucl.2017.04.009_bib63","first-page":"1","article-title":"Analysis of urinary symptoms and urodynamic findings in multiple sclerosis patients by gender and disease subtype","volume":"1","author":"Cox","year":"2015","journal-title":"J\u00a0Neurol Neurobiol"},{"issue":"6","key":"10.1016\/j.ucl.2017.04.009_bib64","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4103\/0366-6999.177970","article-title":"Clinical characteristics and urodynamic analysis of urinary dysfunction in multiple sclerosis","volume":"129","author":"Wang","year":"2016","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"10.1016\/j.ucl.2017.04.009_bib65","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.4081\/ni.2013.e23","article-title":"Urinary dysfunction in women with multiple sclerosis: analysis of 61 patients from rio de janeiro, Brazil","volume":"5","author":"de Almeida","year":"2013","journal-title":"Neurol Int"},{"issue":"4","key":"10.1016\/j.ucl.2017.04.009_bib66","doi-asserted-by":"crossref","first-page":"272","DOI":"10.5213\/inj.2015.19.4.272","article-title":"Association between the neurogenic bladder symptom score and urodynamic examination in multiple sclerosis patients with lower urinary tract dysfunction","volume":"19","author":"Fragala","year":"2015","journal-title":"Int Neurourol J"},{"issue":"1","key":"10.1016\/j.ucl.2017.04.009_bib67","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00345-011-0820-y","article-title":"Which clinical risk factors determine a pathological urodynamic evaluation in patients with multiple sclerosis? An analysis of 100 prospective cases","volume":"31","author":"Wiedemann","year":"2013","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2017.04.009_bib68","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0003-9993(99)90282-4","article-title":"Lower urinary tract dysfunction and disability status in patients with multiple sclerosis","volume":"80","author":"Giannantoni","year":"1999","journal-title":"Arch Phys Med Rehabil"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014317300277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014317300277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:34:29Z","timestamp":1758807269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014317300277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0094014317300277"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2017.04.009","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Urinary Retention in Multiple Sclerosis Patients","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2017.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}